Severe coagulopathy following intraoperative use of topical thrombin

Ann Vasc Surg. 2004 May;18(3):349-51. doi: 10.1007/s10016-004-0028-3.

Abstract

This report describes a case of severe coagulopathy and bleeding related to the intraoperative use of topically applied thrombin. Commercial thrombin preparations contaminated with bovine factor V have been shown to stimulate the production of antibodies directed against factor V. These antibodies can cause coagulopathy. Our patient developed antibodies against factor V after intraoperative exposure to topical thrombin. The resulting antibody-mediated depletion of factor V caused a severe and refractory coagulopathy. Vascular surgeons should be aware that the use of topical bovine thrombin can cause severe coagulopathy.

Publication types

  • Case Reports

MeSH terms

  • Administration, Topical
  • Aged
  • Aged, 80 and over
  • Biomarkers / blood
  • Disseminated Intravascular Coagulation / blood
  • Disseminated Intravascular Coagulation / chemically induced*
  • Disseminated Intravascular Coagulation / diagnostic imaging
  • Factor V / metabolism
  • Hemostatics / adverse effects*
  • Humans
  • Intraoperative Care*
  • Male
  • Partial Thromboplastin Time
  • Postoperative Hemorrhage / blood
  • Postoperative Hemorrhage / chemically induced
  • Postoperative Hemorrhage / diagnostic imaging
  • Prothrombin Time
  • Severity of Illness Index
  • Thrombin / adverse effects*
  • Tomography, X-Ray Computed

Substances

  • Biomarkers
  • Hemostatics
  • Factor V
  • Thrombin